HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ventriculostomy associated haemorrhage: a complication of anti-platelet therapy during coiling.

Abstract
A young man with Fisher grade IV subarachnoid haemorrhage (SAH) underwent aneurysm coiling following external ventriculostomy. Coiling was complicated by thrombus formation and parent vessel occlusion necessitating anti-platelet therapy. Several hours after anti-platelet therapy, catastrophic haemorrhage associated with the ventriculostomy tract occurred. Timing and location of haemorrhage suggest combined anti-platelet therapy and ventriculostomy may have been causal. The literature on ventriculostomy haemorrhage rates and risks with concomitant anti-platelet therapy are reviewed. Where endovascular coiling is being considered, the possibility of ventriculostomy-related haemorrhage should be considered and should influence subsequent treatment decisions.
AuthorsHugh P Sims-Williams, Daniel Weinberg, Changez K Jadun, Howard L Brydon
JournalBritish journal of neurosurgery (Br J Neurosurg) Vol. 28 Issue 6 Pg. 782-4 (Dec 2014) ISSN: 1360-046X [Electronic] England
PMID24810986 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Platelet Aggregation Inhibitors
Topics
  • Adult
  • Endovascular Procedures (adverse effects)
  • Hematoma, Subdural (chemically induced, etiology)
  • Humans
  • Male
  • Platelet Aggregation Inhibitors (adverse effects)
  • Subarachnoid Hemorrhage (drug therapy, surgery)
  • Ventriculostomy (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: